Skip to main content
SpringerLink
Log in

Mid-Trimester Spot Urinary Albumin/Creatinine Ratio as a Screening Tool in Prediction of Pre-eclampsia

  • Original Article
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

Abstract

Aims and Objectives

To determine utilization of spot urinary albumin/creatinine ratio (UACR) to predict subsequent development of preeclampsia, measured between 17 and 24 weeks of gestational age in asymptomatic antenatal woman and determine their maternal and neonatal outcomes.

Introduction

In preeclampsia the basic pathology is generalized endothelial dysfunction. It causes glomerular endotheliosis which leads to proteinuria, decreased glomerular filtration rate and renal blood flow. Thus microalbuminuria is an early marker which can measured to predict preeclampsia.

Materials and Methods

It is a prospective observational study, carried out for one year in a cohort of asymptomatic antenatal women at 17–24 weeks of gestational age, attending hospital for routine antenatal check-up with a singleton pregnancy and no associated complications. Urine albumin and creatinine ratio (UACR) is measured at first visit, and women were followed till delivery and the maternal and foetal outcomes were recorded.

Results

Out of 81 pregnant women enrolled in the study, 58% belonged to 18–25 years, 54.3% belonged to lower middle class. There was a significant difference in mean UACR among women who developed preeclampsia (PE) and gestational diabetes mellitus (GDM) with p value < 0.05. In the study there was significant association between severe PE, PE and GDM with UACR at 22 as cut-off, with p value < 0.05. In the study among those with UACR > 22, 2.5% had IUFD, 12.5% had LBW, and 7.5% were admitted to NICU.

Conclusion

With the measurement of spot UACR in mid-trimester we can predict the development of preeclampsia before the onset of clinical manifestations. UACR > = 171 mg/g predicted preeclampsia well before the onset of clinical manifestations with high sensitivity of 83.3% and specificity of 98.6%.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Martin JN Jr, My O, Keiser SD, et al. Standardized Mississippi protocol treatment of 190 patients with HELLP syndrome: slowing disease progression and preventing new major maternal morbidity. Hypertens Pregnancy. 2012;31(1):79–90. https://doi.org/10.3109/10641955.2010.525277. (Epub 2011 Jan 10. PMID: 21219123).

    Article  CAS  PubMed  Google Scholar 

  2. Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009;30(Suppl. A):S32–7. https://doi.org/10.1016/j.placenta.2008.11.009.

    Article  CAS  PubMed  Google Scholar 

  3. Macdonald-Wallis C, Silberwood RJ, de Stavola BL, et al. Antenatal blood pressure for prediction of preeclampsia, preterm birth, and small for gestational age babies: development and validation in two general population cohorts. BMJ. 2015;351: h5948.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Ohkuchi A, Hirashima C, Takahashi K, et al. Prediction and prevention of hypertensive disorders of pregnancy. Hypertens Res. 2017;40:5–14. https://doi.org/10.1038/hr.2016.107.

    Article  PubMed  Google Scholar 

  5. Arias F, Daftary SN, Bhide AG, et al. Hypertensive Disorders in Pregnancy. In: Arias F, Bhide AG, Arulkumaran S, Damania K, Daftary SN, editors., et al., Practical guide to high risk pregnancy and delivery. A South Asian perspective. New Delhi: Elsevier India; 2015. p. 185–230.

    Google Scholar 

  6. Huang Q, Gao Y, Yu Y, et al. Urinary spot albumin:creatinine ratio for documenting proteinuria in women with preeclampsia. Rev Obstet Gynecol. 2012;5(1):9–15.

    PubMed  PubMed Central  Google Scholar 

  7. Mishra VV, Goyal PA, Priyankur R, et al. Evaluation of spot urinary albumin-creatinine ratio as screening tool in prediction of pre-eclampsia in early pregnancy. J Obstet Gynaecol India. 2017;67(6):405–8.

    Article  CAS  PubMed  Google Scholar 

  8. Kozer E, Costei AM, Boskovic R, et al. Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis. Birth Defects Res Part B Dev Reprod Toxicol. 2013;68:70–84. https://doi.org/10.1002/bdrb.10002.

    Article  CAS  Google Scholar 

  9. Gupta N, Gupta T, Asthana D. Prediction of preeclampsia in early pregnancy by estimating the spot urinary albumin/creatinine ratio. J Obstet Gynecol India. 2017;67(4):258–62. https://doi.org/10.1007/s13224-016-0958-z. (Epub 2016 Dec 19. PMID: 28706364; PMCID: PMC5491411).

    Article  CAS  Google Scholar 

  10. Baweja S, Kent A, Masterson R, et al. Prediction of pre-eclampsia in early pregnancy by estimating the spot urinary albumin: creatinine ratio using high-performance liquid chromatography. BJOG. 2011;118(9):1126–32. https://doi.org/10.1111/j.1471-0528.2011.02960.x. (Epub 2011 Apr 12).

    Article  CAS  PubMed  Google Scholar 

  11. Nisell H, Trygg M, Back R. Urine albumin/creatinine ratio for the assessment of albuminuria in pregnancy hypertension. Acta Obstet Gynecol. 2012;85:1327–30. https://doi.org/10.1080/00016340600808747.

    Article  CAS  Google Scholar 

  12. Sibai BM, Caritis S, Hauth J, et al. Risks of preeclampsia and adverse neonatal outcomes amongwomen with pregestational diabetes mellitus. Am J Obstet Gynaecol. 2000;182:364–9.

    Article  CAS  Google Scholar 

  13. Rodriguez MH, Masaki DI, Mestman J, et al. Calcium/creatinine ratio and microalbuminuria in the prediction of preeclampsia. Am J Obstet Gynecol. 1988;159(6):1452–5.

    Article  CAS  PubMed  Google Scholar 

  14. Shaarawy M, Salem ME. The clinical value of microtransferrinuria and microalbuminuria in the prediction of preeclampsia. Clin Chem Lab Med. 2001;39(1):29–34. https://doi.org/10.1515/CCLM.2001.008. (PMID: 11256797).

    Article  CAS  PubMed  Google Scholar 

  15. Chawla R, Malik S. Microalbuminuria detected at Mid Term as a marker for adverse pregnancy outcome. Int J Health Sci Res. 2018;8(2):41–52.

    Google Scholar 

  16. Bomback AS, Rekhtman Y, Whaley-Connell AT, et al. Gestational diabetes mellitus alone in the absence of subsequent diabetes is associated with microalbuminuria: results from the kidney early evaluation program (KEEP). Diabetes Care. 2010;33(12):2586–91. https://doi.org/10.2337/dc10-1095. (Epub 2010 Aug 31. PMID: 20807871; PMCID: PMC2992195).

    Article  PubMed  PubMed Central  Google Scholar 

  17. Bar J, Hod M, Erman A, et al. Microalbuminuria as an early predictor of hypertensive complications in pregnant women at high risk. Am J Kidney Dis. 1996;28:220–5.

    Article  CAS  PubMed  Google Scholar 

  18. Massé J, Forest JC, Moutquin JM. Microalbumin as a marker of premature delivery. Obstet Gynecol. 1996;87:661–3.

    Article  PubMed  Google Scholar 

  19. Ekbom P, Damm P, Feldt-Rasmussen B, et al. Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care. 2001;24:1739–44.

    Article  CAS  PubMed  Google Scholar 

  20. Singh H, Samal S, Mahapatro A, et al. Comparison of obstetric outcome in pregnant women with and without microalbuminuria. J Nat Sci Biol Med. 2015;6(1):120–4. https://doi.org/10.4103/0976-9668.149106.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

There is no funding for the study.

Author information

Authors and Affiliations

  1. Kamineni Academy of Medical Sciences and Research Centre (KAMSRC), LB Nagar, Hyderabad, Telangana, India

    Akkenapally Prasanna Latha, V. Haripriya & P. Ramya Raj

Authors
  1. Akkenapally Prasanna Latha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Haripriya
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Ramya Raj
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Akkenapally Prasanna Latha.

Ethics declarations

Conflicts of interest

The authors declare that there are no conflicts of interest for the present study.

Ethical standards statement

Ethical standards maintained according to WMA Helinski declaration.

Informed consent

This study was approved by institutional scientific committee and ethical committee. Informed consent was taken from all the participants before enrolment after explaining the study protocol and confidentiality maintained.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Akkenapally Prasanna Latha is an Associate Professor; V. Haripriya is an Associate Professor; P. Ramya Raj is a Resident.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 45 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Latha, A.P., Haripriya, V. & Ramya Raj, P. Mid-Trimester Spot Urinary Albumin/Creatinine Ratio as a Screening Tool in Prediction of Pre-eclampsia. J Obstet Gynecol India 73 (Suppl 2), 234–239 (2023). https://doi.org/10.1007/s13224-023-01862-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-023-01862-9

Keywords

Search

Navigation